Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery
Several startups focused on AI-powered drug discovery have closed multi-million-dollar funding rounds this year, including Causaly, BenchSci, Iktos, TandemAI and Protai. Another one joined the list on Monday. Genesis Therapeutics announced the close of a $200 million Series B funding round, taking the Burlingame, California-based company’s total funding to date to more than $280 million. …